4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001549595-25-000103
Chief Financial Officer sold 5,402 shares at $11.03 ($59,598)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
van Houte Hans · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-01 | Sale : show line 1 in the form 10b5-1 | −5,402 | $11.03 | $59,598 | 35,512 | D |
| Open-market sales · 5,402 sh · avg $11.03 · $59,598 | ||||||
Loading xslF345X05/wk-form4_1754082538.xml…